Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1985-08-01
1986-11-11
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 71, 514450, 549264, A61K 3170, A61K 31365, C07H 1708, C07D49322
Patent
active
046223134
ABSTRACT:
There are disclosed novel O-sulfate derivatives of avermectin and milbemycin. The avermectin and milbemycin O-sulfate derivatives have improved water solubility compared to the parent avermectin and milbemycin compounds and have utility as anti-parasitic agents and as potent insecticides against agricultural pests.
REFERENCES:
patent: 3950360 (1976-04-01), Aoki et al.
patent: 4171314 (1979-10-01), Chabala et al.
patent: 4173571 (1979-11-01), Chabala et al.
patent: 4199569 (1980-04-01), Chabala et al.
patent: 4206205 (1980-06-01), Mrozik et al.
patent: 4310519 (1982-01-01), Albers-Schonberg et al.
patent: 4469682 (1984-09-01), Mrozik
patent: 4470976 (1984-09-01), Miner et al.
Nishino et al., Biochemistry, 18 4340-4347 (1979).
Koster et al., JACS 105 3743-3745 (1983).
Galardy et al., Biochem. J., 226 447-454 (1985).
Brown Johnnie R.
Merck & Co. , Inc.
Mitri Salvatore C.
Peselev Elli
Rose David L.
LandOfFree
O-sulfate derivatives of avermectins and milbemycins having impr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with O-sulfate derivatives of avermectins and milbemycins having impr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and O-sulfate derivatives of avermectins and milbemycins having impr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-377276